Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Appl Microbiol ; 134(2)2023 Feb 16.
Article in English | MEDLINE | ID: mdl-36724282

ABSTRACT

AIMS: To develop a model HACCP plan related to the microbiological hazards for the traditional fermented crab. METHODS AND RESULTS: The microbiological and chemical characteristics of commercial products were surveyed. Microbiological hazard analysis was performed for raw materials and during processing. Critical control points (CCPs) were determined using a decision tree, with CCP1 as saturated salt preparation and CCP2 as fermentation. The critical limit (CL) of CCP1 was at 100°C for 20 min applied to brining and of CCP2 was at 25% NaCl for the brine applied to fermented crab. Isolated microbial hazards and type strains were used for the validation of the CLs. Monitoring and verification of the proposed HACCP plan were carried out, and an effective HACCP plan was established. CONCLUSIONS: The HACCP plan promoted the safe consumption of fermented crab with the provided CCPs at the saturated salt preparation and fermentation steps. The effective CLs to ensure microbiological hazards as safe at the CCPs provide the best support for an effective plan. The hazards were reduced significantly after the HACCP plan had been applied.


Subject(s)
Brachyura , Food Contamination , Animals , Food Contamination/analysis , Food-Processing Industry , Hazard Analysis and Critical Control Points , Seafood , Food Microbiology , Food Handling/methods
2.
Oxid Med Cell Longev ; 2022: 4631983, 2022.
Article in English | MEDLINE | ID: mdl-36187334

ABSTRACT

Oxidative stress and inflammation play key roles in the pathophysiology in the pathophysiology of dyslipidemia, which are positive risks that increase atherosclerosis leading to important healthcare problems. Therefore, we aimed to study the antioxidant, anti-inflammatory, and lipid-lowering effects of jelly drink containing polyphenol-rich roselle calyces extract and passion fruit juice with pulp concentrate (RP jelly drink) in comparison to a placebo jelly drink for 8 weeks. Forty-three adults with dyslipidemia were randomly assigned into two groups: the RP jelly drink group and the placebo group. Glucose, total cholesterol (TC) triglyceride (TG), low-density lipoprotein-cholesterol (LDL-C), high-density lipoprotein-cholesterol (HDL-C), oxidative stress biomarkers, inflammatory parameters, and monocyte chemotactic protein-1 (MCP-1) were measured with fasting blood samples at baseline, 4 weeks and 8 weeks of intervention. Results showed a significant decrease in LDL-C and TG, respectively, after 8 weeks of RP jelly drink consumption (LDL-C: 107.63 ± 22.98 mg/dL; TG: 109.79 ± 38.83 mg/dL) compared to baseline measurements (LDL-C: 128.43 ± 32.74 mg/dL; TG: 132.33 ± 75.11 mg/dL). These may be possible due to reduced inflammation and improvements in oxidative stress, as demonstrated by the reduction of tumor necrosis factor- (TNF-) α and malondialdehyde (MDA), and the enhancement of glutathione (GSH) after consuming the RP jelly drink for 8 weeks. However, no significant differences of treatment on glucose, total cholesterol, MCP-1, interleukin-6, and interleukin-10 were observed. In conclusion, daily consumption of RP jelly drink for 8 weeks resulted in significant improvement in lipid profiles in subjects with dyslipidemia. However, more research is needed to assess its nutritional and functional potential.


Subject(s)
Dyslipidemias , Hibiscus , Adult , Anti-Inflammatory Agents/pharmacology , Anti-Inflammatory Agents/therapeutic use , Antioxidants/pharmacology , Antioxidants/therapeutic use , Biomarkers , Chemokine CCL2 , Cholesterol, HDL , Cholesterol, LDL , Double-Blind Method , Dyslipidemias/drug therapy , Fruit and Vegetable Juices , Glucose , Glutathione/therapeutic use , Humans , Inflammation/drug therapy , Interleukin-10 , Interleukin-6 , Malondialdehyde , Plant Extracts/pharmacology , Plant Extracts/therapeutic use , Polyphenols/pharmacology , Polyphenols/therapeutic use , Triglycerides , Tumor Necrosis Factors/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL